100 related articles for article (PubMed ID: 1851005)
1. Mechanism of inhibition of human cytomegalovirus replication by oxetanocin G.
Daikoku T; Yamamoto N; Saito S; Kitagawa M; Shimada N; Nishiyama Y
Biochem Biophys Res Commun; 1991 Apr; 176(2):805-12. PubMed ID: 1851005
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of human cytomegalovirus replication by a novel nucleoside, oxetanocin G.
Nishiyama Y; Yamamoto N; Takahash K; Shimada N
Antimicrob Agents Chemother; 1988 Jul; 32(7):1053-6. PubMed ID: 2847638
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of triphosphate derivatives of oxetanocin G and related compounds on eukaryotic and viral DNA polymerases and human immunodeficiency virus reverse transcriptase.
Izuta S; Shimada N; Kitagawa M; Suzuki M; Kojima K; Yoshida S
J Biochem; 1992 Jul; 112(1):81-7. PubMed ID: 1385392
[TBL] [Abstract][Full Text] [Related]
4. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
Saijo M; Suzutani T; Yoshida I
Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
[TBL] [Abstract][Full Text] [Related]
5. Effect of oxetanocin G, a novel nucleoside analog, on DNA synthesis by hepatitis B virus virions.
Nagahata T; Kitagawa M; Matsubara K
Antimicrob Agents Chemother; 1994 Apr; 38(4):707-12. PubMed ID: 7518217
[TBL] [Abstract][Full Text] [Related]
6. Anti-herpesvirus activity of carbocyclic oxetanocin G in vitro.
Nishiyama Y; Yamamoto N; Yamada Y; Daikoku T; Ichikawa Y; Takahashi K
J Antibiot (Tokyo); 1989 Dec; 42(12):1854-9. PubMed ID: 2559911
[TBL] [Abstract][Full Text] [Related]
7. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.
Tenney DJ; Yamanaka G; Voss SM; Cianci CW; Tuomari AV; Sheaffer AK; Alam M; Colonno RJ
Antimicrob Agents Chemother; 1997 Dec; 41(12):2680-5. PubMed ID: 9420038
[TBL] [Abstract][Full Text] [Related]
8. Potency and Stereoselectivity of Cyclopropavir Triphosphate Action on Human Cytomegalovirus DNA Polymerase.
Chen H; Li C; Zemlicka J; Gentry BG; Bowlin TL; Coen DM
Antimicrob Agents Chemother; 2016 Jul; 60(7):4176-82. PubMed ID: 27139481
[TBL] [Abstract][Full Text] [Related]
9. A proposed mechanism for the selective inhibition of human cytomegalovirus replication by 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-fluorouracil.
Suzuki S; Misra HK; Wiebe LI; Knaus EE; Tyrrell DL
Mol Pharmacol; 1987 Mar; 31(3):301-6. PubMed ID: 3031445
[TBL] [Abstract][Full Text] [Related]
10. Antiviral effect of oxetanocin G against guinea pig cytomegalovirus infection in vitro and in vivo.
Yamamoto N; Yamada Y; Daikoku T; Nishiyama Y; Tsutsui Y; Shimada N; Takahashi K
J Antibiot (Tokyo); 1990 Dec; 43(12):1573-8. PubMed ID: 2177463
[TBL] [Abstract][Full Text] [Related]
11. Synthetic nucleosides and nucleotides. 43. Inhibition of vertebrate telomerases by carbocyclic oxetanocin g (C.OXT-G) triphosphate analogues and influence of C.OXT-G treatment on telomere length in human HL60 cells.
Yamaguchi T; Saneyoshi M; Takahashi H; Hirokawa S; Amano R; Liu X; Inomata M; Maruyama T
Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):539-51. PubMed ID: 16838844
[TBL] [Abstract][Full Text] [Related]
12. Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes.
Koyano S; Suzutani T; Yoshida I; Azuma M
Antimicrob Agents Chemother; 1996 Apr; 40(4):920-3. PubMed ID: 8849252
[TBL] [Abstract][Full Text] [Related]
13. Emergence of resistance to carbocyclic oxetanocin G in herpes simplex virus type 1 and genetic analysis of resistant mutants.
Hu N; Shiota H
Acta Pharmacol Sin; 2004 Jul; 25(7):921-6. PubMed ID: 15210066
[TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of selective inhibition of human cytomegalovirus replication by 1-beta-D-arabinofuranosyl-5-fluorouracil.
Suzuki S; Saneyoshi M; Nakayama C; Nishiyama Y; Yoshida S
Antimicrob Agents Chemother; 1985 Aug; 28(2):326-30. PubMed ID: 3010844
[TBL] [Abstract][Full Text] [Related]
16. Acyclic guanosine analogs as inhibitors of human cytomegalovirus.
Wahren B; Larsson A; Rudén U; Sundqvist A; Sølver E
Antimicrob Agents Chemother; 1987 Feb; 31(2):317-20. PubMed ID: 3032096
[TBL] [Abstract][Full Text] [Related]
17. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiviral activity of carbocyclic oxetanocin analogues (C-OXT-A, C-OXT-G) and related compounds. II.
Maruyama T; Hanai Y; Sato Y; Snoeck R; Andrei G; Hosoya M; Balzarini J; De Clercq E
Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):516-21. PubMed ID: 8386594
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of herpes simplex virus type 1 DNA polymerase by [1R(1 alpha,2 beta,3 alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl] guanine.
Terry BJ; Cianci CW; Hagen ME
Mol Pharmacol; 1991 Oct; 40(4):591-6. PubMed ID: 1656194
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of oxetanocins against varicella-zoster virus.
Sakuma T; Saijo M; Suzutani T; Yoshida I; Saito S; Kitagawa M; Hasegawa S; Azuma M
Antimicrob Agents Chemother; 1991 Jul; 35(7):1512-4. PubMed ID: 1656865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
